Syquant Capital Sas’s Verona Pharma PLC Position
Does Syquant Capital Sas own Verona Pharma PLC (VRNA)? Not currently — the last reported position was 1.21M shares worth $129M in Q3 2025; the fund’s latest 13F (Q2 2026) no longer reports it.
Position Value
$129M
Q3 2025
Shares
1.21M
% of Portfolio
+37.01%
Quarters Held
1
position exited
Position History VRNA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2025 | 1.21M | $129M | +37.01% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Syquant Capital Sas’s full portfolio or all institutional holders of VRNA.